— Know what they know.
Not Investment Advice

CALZF OTC

Polynovo Limited
1W: -17.7% 1M: -12.7% 3M: +0.0% YTD: -20.5% 1Y: -34.7% 3Y: -61.2%
$0.62
-0.13 (-17.69%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 40 · $428.3M mcap · 617M float · 0.0022% daily turnover · Short 90% of daily vol

Income Trends

Revenue
$144M +12.8% ▲
5Y CAGR: +37.5%
Gross Profit
$47M -61.6% ▼
5Y CAGR: +11.2%
Operating Income
$10M +133.1% ▲
Net Income
$7M -44.5% ▼
EPS (Diluted)
$0.01 -44.4% ▼
EBITDA
$14M +33.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$41M$65M$103M$127M$144M
YoY Growth+42.1%+57.4%+58.2%+23.3%+12.8%
Cost of Revenue$25M$4M$5M$5M$97M
Gross Profit$39M$61M$98M$122M$47M
Gross Margin94.7%93.2%94.7%95.9%32.7%
R&D Expenses$6M$7M$11M$8M$5M
SG&A Expenses$30M$53M$79M$99M$31M
Operating Expenses$16M$67M$97M$118M$36M
Operating Income-$257K-$6M$1M$4M$10M
Operating Margin-0.6%-9.5%1.1%3.5%7.3%
Interest Expense$315K$714K$721K$236K$920K
Income Before Tax-$1M-$5M$2M$8M$8M
Tax Expense$42K-$9K-$4M-$6M$476K
Net Income-$1M-$5M$5M$13M$7M
Net Margin-2.9%-7.5%5.1%10.4%5.1%
EPS (Diluted)$-0.00$-0.01$0.01$0.02$0.01
EBITDA$658K-$3M$4M$10M$14M
Shares Outstanding661M684M701M699M698M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms